Controversies in the Management of Adult Sarcomas - 2020 Annual Meeting

Soft tissue sarcomas are rare and involve a well-integrated multi-modality approach to optimize outcomes and decrease morbidity. A recent report published by Sarcoma UK showed that 75% of the population "do not know what sarcoma is." This lack of knowledge has translated to the incidence of unplanned excisions, increasing morbidity, and inferior outcomes. It is also one of the many reasons that sarcomas should be managed at a high-volume center. Management of sarcomas in such centers lead to improved oncologic outcomes, and thus, it is important for oncologists to have a good working knowledge and multi-disciplinary collaboration. In the proposed didactic session on "Controversies in the Management of Adult Sarcomas", speakers will provide an overview of adult sarcoma and extensively discuss management for common and often controversial clinical scenarios that many sarcoma providers encounter such as, unplanned excisions, pediatric sarcomas in adults, hypofractionated radiotherapy, and use of chemotherapy in localized disease.

 

This activity is available from December 16 2020, through 11:59 p.m. Eastern time on December 15, 2023.

This activity was originally recorded at ASTRO’s virtual 2020 Annual Meeting, October 23-28th.

Target Audience

The activity is designed to meet the interests of radiation oncologists, medical oncologists, surgeons, radiation physicists, radiation therapists, radiation dosimetrists, nurses, specialists, and radiation oncology residents. 

Learning Objectives

    Upon completion of this activity, learners should be able to:

    1. Discuss the management of unplanned excisions and integration of care across disciplines.
    2. Analyze the data regarding radiation in RPS, pediatric sarcomas in adults and chemotherapy in localized soft tissue sarcomas and determine optimal use on varying patient populations.
    3. Implement the knowledge learned to educate patients on expectations, outcomes and methods to minimize toxicity.
    Course summary
    Available credit: 
    • 1.25 Certificate of Attendance
      This activity was designated for 1.25 AMA PRA Category 1 Credit™.
    • 1.25 SA-CME

      The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council of Continuing Medical Education to provide continuing medical education for physicians.

      The American Society for Radiation Oncology (ASTRO) designates this Enduring material for a maximum of 1.25 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

      This activity meets the American Board of Radiology's criteria for a self-assessment activity in the ABR's Maintenance of Certification program. Participation in this course in combination with the successful completion of the corresponding assessment and course evaluation adheres to the guidelines established by the ABR for 1.25 self-assessment credits.

    Course opens: 
    12/16/2020
    Course expires: 
    12/15/2023
    Cost:
    $105.00
    Rating: 
    0
    • Jonathan Trent, MD, PhD is employed at University of Miami, Sylvester Comprehensive Cancer Center and has no financial relationships with a commercial interest. 
    • David M. King, MD is employed at Medical College of Wisconsin and has no financial relationships with a commercial interest. 
    • Manpreet Bedi, MD is employed at Medical College of Wisconsin and has no financial relationships with a commercial interest. 
    • Yen-Lin Evelyn Chen is employed at Massachusetts General Hospital and has family employed at Beth Israel Deaconess Medical Center and Massachusetts General Hospital. Dr. Chen has no financial relationships with a commercial interest. 

    The person(s) above served as the developer(s) of this activity. Additionally, the Education Committee had control over the content of this activity. All relevant relationships have been mitigated.

    Disclosure link: 
    Committee Disclosures

    The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council of Continuing Medical Education to provide continuing education to physicians.

    ASTRO is awarded Deemed Status by the American Board of Radiology to provide SA-CME as part of Part II Maintenance of Certification. 

    Available Credit

    • 1.25 Certificate of Attendance
      This activity was designated for 1.25 AMA PRA Category 1 Credit™.
    • 1.25 SA-CME

      The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council of Continuing Medical Education to provide continuing medical education for physicians.

      The American Society for Radiation Oncology (ASTRO) designates this Enduring material for a maximum of 1.25 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

      This activity meets the American Board of Radiology's criteria for a self-assessment activity in the ABR's Maintenance of Certification program. Participation in this course in combination with the successful completion of the corresponding assessment and course evaluation adheres to the guidelines established by the ABR for 1.25 self-assessment credits.

    Price

    Cost:
    $105.00
    Please login or register to take this course.

    Course Fees:
    ASTRO members must log in to the ASTRO website to view and receive the discounted member rate.

    • Nonmember: $105
    • Member: $55

    Policies:
    No refunds, extensions, or substitutions will be made for those participants who, for any reason, have not completed the course by the end of the qualification date. The qualification date for each course is listed in the course catalog on the ASTRO website under availability.

    Participants using ASTRO's online courses to satisfy the requirement of a Maintenance of Certification (MOC) program should verify the number, type and availability dates of any course before making a purchase. No refunds, extensions, or substitutions will be made for participants who have purchased courses that do not align with their MOC requirement.

    The course and its materials will only be available on the ASTRO website for that 3 year period regardless of purchase date. At the expiration of the qualification, participants will no longer have access to the course or its materials. ASTRO reserves the right to remove a course before the end of its qualification period.

    Required Hardware/software

    One of the two latest versions of Google Chrome, Mozilla Firefox, Internet Explorer or Safari.